Search results
Google site results
Loading...
Wiki results
- ==Cancer Category/Type== ===Role in Cancer===20 KB (2,904 words) - 03:02, 13 August 2018
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==19 KB (2,643 words) - 13:51, 25 February 2024
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==31 KB (4,325 words) - 13:55, 25 February 2024
- ...&t=1s <u>A Resource for our Clinical Genomics Community: the Compendium of Cancer Genome Aberrations (CCGA) - YouTube</u>]''' ''iv) Research/experience in disease/genes of interest''10 KB (1,712 words) - 14:21, 12 December 2023
- ==Cancer Category/Type== ...tyrosine kinase receptor gene FGFR1, located in 8p11, and several partner genes, including ZMYM2 (wang et al).10 KB (1,469 words) - 17:05, 11 October 2018
- ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==34 KB (4,782 words) - 16:37, 20 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==20 KB (2,747 words) - 14:28, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==25 KB (3,503 words) - 14:24, 13 December 2023
- Hui Chen, MD, PhD, The University of Texas MD Anderson Cancer Center ==Cancer Category/Type==9 KB (1,336 words) - 16:42, 16 April 2024
- Cancer Metastasis Rev (2014) 33:1109–1124 PMID:[http://www.ncbi.nlm.nih.gov/pubm ...gnature PI3K/AKT and mTOR pathways elevated; high expression of several genes representing targets for immunotherapy including PDCD1, CD247, PDCD1LG2, CT8 KB (1,050 words) - 16:48, 19 August 2016
- ...yrosine kinase; Abelson tyrosine-protein kinase 1; ABL; JTK7; p150; c-ABL; v-abl; CHDSKM; c-ABL1; bcr/abl ==Cancer Category/Type==12 KB (1,695 words) - 13:43, 12 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==21 KB (2,936 words) - 14:33, 13 December 2023
- ...Table derived from Chun et al., 2018 [PMID 30554732] with permission from Cancer Genetics. |'''Relevant Genes'''40 KB (5,707 words) - 22:25, 7 November 2020
- ...inal page can be found at [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged]]. ==Cancer Category / Type==12 KB (1,796 words) - 14:21, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==22 KB (3,077 words) - 14:26, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==30 KB (4,118 words) - 14:20, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==22 KB (3,152 words) - 14:16, 13 December 2023
- ==Cancer Category / Type== ==Cancer Sub-Classification / Subtype==48 KB (6,794 words) - 14:27, 13 December 2023
- ==Cancer Category/Type== '''Breast Cancer'''36 KB (5,335 words) - 14:18, 12 December 2023
- |Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center |Ruth MacKinnon PhD Victorian Cancer Cytogenetics Service Melbourne, Australia61 KB (7,864 words) - 16:23, 16 April 2024